ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 0.00 | – | 0.00 | 0.00 | |
| 1.03 | 1.01 | 0.66 | 0.96 | 0.90 | 0.94 | 0.92 | 0.75 | – | – | – | – | |
| -1.03 | -1.01 | -0.66 | -0.96 | -0.90 | -0.94 | -0.92 | -0.75 | – | – | – | – | |
| 40.30 | 40.11 | 38.85 | 24.78 | 16.74 | 17.71 | 11.62 | 5.00 | 1.47 | – | 0.38 | 0.42 | |
| – | – | – | – | – | – | – | – | 2.06 | – | 0.49 | 0.24 | |
| 58.21 | 54.61 | 51.62 | 35.30 | 29.70 | 26.90 | 19.66 | 13.81 | 3.53 | – | 0.87 | 0.66 | |
| -59.24 | -55.62 | -52.28 | -36.26 | -30.61 | -27.84 | -20.58 | -14.56 | -3.53 | – | -0.87 | -0.66 | |
| 2.32 | 2.05 | 2.41 | 2.48 | 2.95 | 2.46 | 1.14 | 0.94 | 1.40 | – | 0.01 | 0.00 | |
| -61.58 | -59.00 | -53.91 | -38.12 | -32.48 | -31.63 | -21.58 | -14.38 | -4.94 | – | -0.86 | -0.66 | |
| – | – | – | – | -0.39 | – | – | – | – | – | – | – | |
| -61.58 | -59.00 | -53.91 | -38.12 | -32.09 | -31.63 | -21.58 | -14.38 | -4.94 | – | -0.86 | -0.66 | |
| -58.23 | -55.95 | -50.85 | -34.68 | -28.62 | -28.23 | -19.52 | -12.69 | -3.54 | – | -0.85 | -0.66 |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.